<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>POTASSIUM CITRATE-CITRIC ACID- potassium citrate and citric acid monohydrate solution </strong><br>Method Pharmaceuticals, LLC<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Potassium Citrate-Citric Acid Solution</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_4edee3eb-5e3a-4d4e-aa81-6e5f37619602"></a><a name="section-1"></a><p></p>
<h1></h1>
<p class="First">Rx Only</p>
<p>NDC 58657-412-16</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_67a37bd2-dbaa-4da7-95b5-a6f8d134decf"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Potassium Citrate-Citric Acid Solution is a stable and pleasant-tasting oral systemic alkalizer containing potassium citrate and citric acid in a sugar-free, non-alcoholic base. </p>
<p>Potassium Citrate-Citric Acid Solution contains in each teaspoonful (5 mL):</p>
<p>Potassium Citrate Monohydrate ......  1100 mg</p>
<p>Citric Acid Monohydrate ...................   334 mg</p>
<p>Each mL contains 2 mEq potassium ion and is equivalent to 2 mEq <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> (HCO3).</p>
</div>
<div class="Section" data-sectionCode="51727-6">
<a name="LINK_f666ea21-5c3a-4705-8219-5219181e9b57"></a><a name="section-3"></a><p></p>
<h1>INACTIVE INGREDIENTS</h1>
<p class="First">propylene glycol, sorbitol, polyethylene glycol 400, methylparaben, propylparaben, sucralose, FD&amp;C red #40, cherry flavor, and purified water.</p>
</div>
<div class="Section" data-sectionCode="43679-0">
<a name="LINK_66de2d9c-a42f-4dc8-8e42-2de6b7a27aee"></a><a name="section-4"></a><p></p>
<h1>ACTIONS</h1>
<p class="First">Potassium citrate is absorbed and metabolized to potassium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>, thus acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonates</span> subsequently. Oxidation is virtually complete so that less than 5% of the potassium citrate is excreted in the urine unchanged.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_8aec7ad3-8911-490c-ba7f-1cb3391d4efb"></a><a name="section-5"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Potassium Citrate-Citric Acid Solution is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in <span class="product-label-link" type="condition" conceptid="440674" conceptname="Gout">gout</span> therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span> of certain <span class="product-label-link" type="condition" conceptid="4318544" conceptname="Renal tubular disorder">renal tubular disorders</span> where the administration of potassium citrate may be preferable. This product is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic <span class="product-label-link" type="condition" conceptid="438730" conceptname="Alkalosis">alkalosis</span> in recommended dosage. It is highly palatable, pleasant tasting and tolerable, even when administered for long periods. Potassium citrate does not neutralize the gastric juice or disturb digestion.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_4a5a224a-d4a2-4ae0-988d-c371b3bb3dfe"></a><a name="section-6"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> with <span class="product-label-link" type="condition" conceptid="4306451" conceptname="Oliguria">oliguria</span> or <span class="product-label-link" type="condition" conceptid="4261202" conceptname="Uremia">azotemia</span>, untreated Addison’s disease, adynamia episodica hereditaria, acute <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>, heat <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">cramps</span>, <span class="product-label-link" type="condition" conceptid="4090272" conceptname="Anuria">anuria</span>, severe myocardial damage, and <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> from any cause.  Known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any ingredient. </p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_63cc9707-803d-4dd8-9b94-d48a25372f8b"></a><a name="section-7"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">There have been several reports, published and unpublished, concerning nonspecific small-bowel lesions consisting of stenosis, with or without ulceration, associated with the administration of enteric-coated thiazides with potassium salts. These lesions may occur with enteric-coated potassium tablets alone or when they are used with nonenteric- coated thiazides, or certain other oral diuretics. These small-bowel lesions have caused obstruction, <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span>, and perforation. Surgery was frequently required and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">deaths</span> have occurred. Based on a large survey of physicians and hospitals, both United States and foreign, the incidence of these lesions is low, and a causal relationship in man has not been definitely established. Available information tends to implicate enteric-coated potassium salts, although lesions of this type also occur spontaneously. Therefore, coated potassium-containing formulations should be administered only when indicated, and should be discontinued immediately if <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, or <span class="product-label-link" type="condition" conceptid="192671" conceptname="Gastrointestinal hemorrhage">gastrointestinal bleeding</span> occur. </p>
<p>Large doses may cause <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> and <span class="product-label-link" type="condition" conceptid="438730" conceptname="Alkalosis">alkalosis</span>, especially in the presence of <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>. Concurrent administration of potassium-containing medication, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, or cardiac glycosides may lead to toxicity. Do not exceed recommended dosage. Discontinue use if adverse reaction occurs. </p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_d8d932b6-c8a2-448c-b19f-d97c63c1416a"></a><a name="section-8"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Should be used with caution by patients with low urinary output unless under the supervision of a physician. As with all liquids containing a high concentration of potassium, patients should be directed to dilute adequately with water to minimize the possibility of <span class="product-label-link" type="condition" conceptid="4168618" conceptname="Injury of gastrointestinal tract">gastrointestinal injury</span> associated with the oral ingestion of concentrated potassium salt preparations; and preferably, to take each dose after meals to avoid saline laxative effect.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_24d400d0-8989-49c8-9011-9999e6a320b9"></a><a name="section-9"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Potassium Citrate-Citric Acid Solution is generally well tolerated without any unpleasant side effects when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> or <span class="product-label-link" type="condition" conceptid="438730" conceptname="Alkalosis">alkalosis</span>. Potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> causes <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span> of extremities, and other symptoms associated with a high concentration of potassium in the serum. Periodic determinations of serum electrolytes should be carried out in those patients with <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span> in order to avoid these complications. <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">Hyperkalemia</span> may exhibit the following electrocardiographic abnormalities: Disappearance of the P wave, widening and slurring of <span class="product-label-link" type="condition" conceptid="4064625" conceptname="QRS complex feature">QRS complex</span>, changes of the S-T segment, tall peaked T waves, etc.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="LINK_1fd19ae7-f7ab-42f1-a4df-c7e2e57c4fd0"></a><a name="section-10"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">The administration of oral potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>. However, if excretory mechanisms are impaired, <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> can result (see <a href="#LINK_4a5a224a-d4a2-4ae0-988d-c371b3bb3dfe">Contraindications</a> and <a href="#LINK_63cc9707-803d-4dd8-9b94-d48a25372f8b">Warnings</a>). <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">Hyperkalemia</span>, when detected, must be treated immediately because lethal levels can be reached in a few hours. </p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_a1fa4bb3-be28-4b63-80a8-ed26efb22e64"></a><a name="section-11"></a><p></p>
<h1>TREATMENT OF <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">HYPERKALEMIA</span></h1>
<p class="First">Should <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> occur, treatment measures include the following: (1) Elimination of foods or medications containing potassium. (2) The intravenous administration of 300 to 500 mL/hr of dextrose solution (10 to 25%), containing 10 units of insulin/20 gm dextrose. (3) The use of exchange resins, hemodialysis, or peritoneal dialysis. In treating <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, it should be recalled that in patients who have been stabilized on digitalis, too rapid a lowering of the plasma potassium concentration can produce <span class="product-label-link" type="condition" conceptid="433667" conceptname="Poisoning by tetanus vaccine">digitalis toxicity</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_66764082-b019-44f4-a573-77cf3c4e2d96"></a><a name="section-12"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Potassium Citrate-Citric Acid Solution should be taken diluted in water according to directions, followed by additional water, if desired. Palatability is enhanced if chilled before taking.</p>
<p>Proper dilution may help prevent <span class="product-label-link" type="condition" conceptid="4168618" conceptname="Injury of gastrointestinal tract">gastrointestinal injury</span> associated with the oral ingestion of concentrated potassium salt preparations.  </p>
<p>Usual Adult Dose: 3 to 6 teaspoonfuls (15 to 30 mL), diluted with 1 glass of water, after meals and at bedtime, or as directed by a physician.</p>
<p>Usual Pediatric Dose: 1 to 3 teaspoonfuls (5 to 15 mL), diluted with 1/2 glass of water, after meals and at bedtime, or as directed by a physician.</p>
<p>Usual Dosage Range: 2 to 3 teaspoonfuls (10 to 15 mL), diluted with a glassful of water, taken four times a day. Potassium Citrate-Citric Acid Solution, diluted with a glassful of water, taken four times a day will usually maintain a urinary pH of 7.0-7.6 throughout most of the 24 hours without unpleasant side effects. To check urinary pH, HYDRION Paper (pH 6.0-8.0) or NITRAZINE Paper (pH 4.5-7.5) are available and easy to use.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_1563533a-3c3f-4078-94b5-03cf3244e3e8"></a><a name="section-13"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Potassium Citrate-Citric Acid Solution is a (red colored; cherry flavored) oral solution and is supplied in the following oral dosage form: NDC 58657-412-16 (16 fl oz bottles).</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="LINK_d5f6ee16-3a90-4b75-9999-ce5aadf296b2"></a><a name="section-14"></a><p></p>
<h1>STORAGE</h1>
<p class="First">Keep tightly closed. Store at controlled room temperature, 20°-25° C (68°-77° F). Protect from excessive heat and freezing.</p>
<p>Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.</p>
<p>Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure.</p>
<p>KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSAGE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.</p>
<p>Call your doctor for medical advice about side effects. To report an adverse event, please contact Method Pharmaceuticals, LLC at (877)250-3427.</p>
<p>Distributed by:</p>
<p>Method Pharmaceuticals, LLC </p>
<p>Arlington, TX 76006              Rev. 10/2014</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_a84e5cc3-c078-40b8-953d-32ca23df1551"></a><a name="section-15"></a><p></p>
<h1><span class="Bold">PRINCIPAL DISPLAY PANEL</span></h1>
<p class="First"><span class="Bold">NDC 58657-412-16</span></p>
<p><span class="Bold">Potassium Citrate-</span><br><span class="Bold">Citric Acid </span><br><span class="Bold">Solution</span><span class="Bold"><br>1100 mg/334 mg per 5 mL</span><span class="Bold"><br>Rx Only</span><span class="Bold"><br>SHAKE WELL BEFORE USE</span><br><span class="Bold">16 fl oz (473 mL)</span></p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL NDC 58657-412-16 Potassium Citrate- Citric Acid Solution 1100 mg/334 mg per 5 mL Rx Only SHAKE WELL BEFORE USE 16 fl oz (473 mL)" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d17c575a-9db1-4531-95b1-2c1b4628c1d7&amp;name=potassium-citrate-citric-acid-solution-1.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POTASSIUM CITRATE-CITRIC ACID 		
					</strong><br><span class="contentTableReg">potassium citrate and citric acid monohydrate solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:58657-412</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM CITRATE</strong> (ANHYDROUS CITRIC ACID) </td>
<td class="formItem">POTASSIUM CITRATE</td>
<td class="formItem">1100 mg  in 5 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>CITRIC ACID MONOHYDRATE</strong> (ANHYDROUS CITRIC ACID) </td>
<td class="formItem">ANHYDROUS CITRIC ACID</td>
<td class="formItem">334 mg  in 5 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POTASSIUM CATION</strong></td>
<td class="formItem">10 meq  in 5 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PROPYLENE GLYCOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SORBITOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 400</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>METHYLPARABEN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PROPYLPARABEN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SUCRALOSE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C RED NO. 40</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">RED</td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">CHERRY</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:58657-412-16</td>
<td class="formItem">473 mL in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">UNAPPROVED DRUG OTHER</td>
<td class="formItem"></td>
<td class="formItem">10/20/2014</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Method Pharmaceuticals, LLC
							(060216698)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 10/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>6167bf45-3d21-4400-9861-5b1d1ea199ee</div>
<div>Set id: d17c575a-9db1-4531-95b1-2c1b4628c1d7</div>
<div>Version: 2</div>
<div>Effective Time: 20141020</div>
</div>
</div> <div class="DistributorName">Method Pharmaceuticals, LLC</div></p>
</body></html>
